Pomerantz Law Firm Investigates Astrana Health for Potential Securities Fraud
The law firm of Pomerantz LLP is investigating potential securities fraud or other unlawful business practices by Astrana Health, Inc. (NASDAQ: ASTH) and certain officers or directors on behalf of investors. The investigation was prompted in part by a short report from Glass House Research published on September 17, 2026, which raised concerns about the company's reliance on aggressive acquisitions rather than organic growth, subjective management estimates, a $545 million related-party loan, and potential regulatory exposure with Medicare in 2027. Following this report, Astrana’s stock price dropped by nearly 9% to close at $34.30 per share. Pomerantz LLP is one of the leading firms specializing in corporate litigation, particularly class actions involving securities fraud or fiduciary breaches. The firm has a long history and notable success in recovering damages for affected investors. Investors are encouraged to contact Danielle Peyton with Pomerantz for more information.
Tickers: $ASTH
Topics: corporate_governance investor_protection stock_price_drop
Read the full article at PR Newswire
Part of the story Investor Alert: Pomerantz Law Firm Investigates Pasqal Holding SA for Potential Securities Fraud (5 articles)